SOLIRIS® (eculizumab) Home | HCP Site - Alexion
SOLIRIS® (eculizumab) is used to treat patients with NMOSD. Please see Important Safety Information, including Boxed Warning, and Medication Guide.
Soliris: Usage, Dosage, Side Effects, Warnings - Drugs.com
May 26, 2025 · Soliris (eculizumab) is used to treat paroxysmal nocturnal hemoglobinuria (PNH) in adults, and a rare chronic blood disease called atypical hemolytic uremic syndrome (aHUS) in adults …
ULTOMIRIS and SOLIRIS REMS - Home
Sep 16, 2024 · ULTOMIRIS ® and SOLIRIS ® are available only through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS), called the ULTOMIRIS and SOLIRIS REMS, …
Use of SOLIRIS in pediatric patients for this indication is supported by evidence from four adequate and well-controlled clinical studies assessing the safety and effectiveness of SOLIRIS for...
SOLIRIS® - medicalinformation.astrazeneca-us.com
Find prescribing information for SOLIRIS® (eculizumab), an intravenous injection, on this webpage.
Eculizumab - Wikipedia
Eculizumab, sold under the brand name Soliris among others, is a recombinant humanized monoclonal antibody used to treat paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, …
Eculizumab (Soliris) - Uses, Side Effects, and More - WebMD
Aug 14, 2025 · Find patient medical information for Eculizumab (Soliris) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
Soliris: Cost, dosage, side effects, uses, interactions, and more
Jun 6, 2024 · Soliris (eculizumab) is a prescription injection used to treat certain autoimmune conditions in adults and some children. Learn about cost, dosage, and more.
SOLIRIS® (eculizumab) HCP | Resources - alexion.com
Resources to help start your patients on SOLIRIS® (eculizumab). Please see Important Safety Information, including Boxed Warning, and Medication Guide.
SOLIRIS® (eculizumab) injection, for intravenous use Initial U.S ...
SOLIRIS is indicated for the treatment of generalized myasthenia gravis (gMG) in adult and pediatric patients six years of age and older who are anti-acetylcholine receptor (AChR) antibody...